The American Society of Dermatopathology

Continuing Medical Education

Continuing Medical Education

Earn up to 35 AMA PRA Category 1 CreditsTM

The American Society of Dermatopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Dermatopathology designates this live activity for a maximum of 35 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Medical Education Policy

The American Society of Dermatopathology (ASDP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME). As such, we are required to meet the ACCME’s expectations for our practice of continuing medical education.

It is the policy of ASDP to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Faculty participating in and planning the Annual Meeting must comply with all procedures governing disclosure. The ASDP has implemented a process where everyone in a position to control the content of an educational activity will present evidence-based content, disclose all relevant financial relationships with any commercial interest and discussion of unlabeled/investigational uses of a commercial product. In addition, presentations must be free of commercial bias and any information regarding commercial products/services must be based on scientific methods generally accepted by the medical community. Conflicts will be resolved prior to this educational activity. Faculty who refuse to disclose relevant financial relationships and discussion of unlabeled/investigational uses of a commercial product will be disqualified from being a part of the planning and implementation of this CME activity.

Presenters who qualify for the implementation of this activity are required to verbally disclose to the audience, immediately prior to the scientific presentation, any of the relationships mentioned above. Faculty relationships will also be disclosed to audience in annual meeting printed materials.

CME Claims and Verification of Attendance

Important! Attendees will be able to claim their CME credits online via the ASDP website after the meeting. You must submit your CME credit online in order to receive appropriate CME credit. The number of CME credit available for each course/session is indicated on the website and on the online CME submission site. An official CME certificate will be available to print immediately after completing the online CME claim form and evaluation. Paper certificates will not be mailed.

CC/MOC Claims and Verification

CC/MOC credit for the Self-Assessment in Dermatopathology session will not be included on the Annual Meeting CME certificate. Participants must complete the post-course online self-assesment with a score of 75 percent or better in order to claim CC/MOC credit for the Self-Assessment in Dermatopathology. A CC/MOC certificate will be available to print upon successful completion of the post-course online self-assessment.

Learning Objectives

The educational misson of the ASDP is to teach, aid in the dissemination of knowledge and encouage research to improve the quality of the practice of dermatopathology. The annual meeting is primarily an educational one, offering members, fellows, residents and medical students lectures on current topics in dermatopathology, interactive sessions at the microscope, a self-assessment course, and opportunities for poster and oral abstract presentations. 

After attending the 2020 Annual Meeting, participants should be able to:
  • Recognize histologic features of common, rare and unusual entities in dermatopathology. 
  • Differentiate clinicopathologic features of various emerging and opportunistic infectious diseases in dermatopathology.
  • Identify histologic features of common cutaneous adverse reactions from immunotherapies and/or targeted therapies.
  • Differentiate between clinicopathologic features of permanent chemotherapy-induced alopecia and medications related to specific alopecia patterns.
  • Recognize and apply set immunohistochemical panels to successfully diagnose/distinguish cutaneous tumors, resulting in improved patient care and outcomes.
  • Apply appropriate immunohistochemistry, multiplex immunohistochemistry or molecular tests as biomarkers to improve patient outcomes in dermatopathology cases.
  • Identify opportunities to improve practice of dermatopathology by recognizing and addressing common diagnostic pitfalls, difficulties in reviewing complex cases and challenges posed by ambiguous tumors.
  • Demonstrate greater understanding of the impact of recent legislation and advocacy efforts on the field and practice of dermatopathology.
  • Identify and address professional practice gaps in handling routine dermatopathology cases. 
  • Describe advantages and disadvantages of participating in various practice models in dermatopathology.